Quality of life according to add-back therapy during GnRH agonist treatment in endometriosis patients
article
OA: bronze
CC0
AI-generated summary
This study investigated how add-back therapy influences the quality of life for endometriosis patients undergoing postoperative gonadotropin-releasing hormone agonist treatment.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
This study was performed to investigate the effect of add-back therapy on quality of life during postoperative gonadotropin-releasing hormone (GnRH) agonist therapy for endometriosis.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (22)
- Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached? via openalex
- Add-back therapy in the treatment of endometriosis-associated pain via openalex
- Add-back therapy use and its impact on LA persistence in patients with endometriosis via openalex
- Correction to: "Friedman AJ, Hornstein MD: Gonadotropin-releasing hormone agonist plus estrogen-progestin "add-back" therapy for endometriosis-related pelvic pain. Fertil Steril 1993;60:236-41" via openalex
- Endometriosis via openalex
- Endometriosis: Treatment Strategies via openalex
- GnRH analogs: Options for endometriosis-associated pain treatment via openalex
- Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show? via openalex
- Gonadotropin-releasing hormone agonist plus estrogen-progestin “add-back” therapy for endometriosis-related pelvic pain via openalex
- Gonadotropin-Releasing Hormone Agonists for Endometriosis via openalex
- Hormone treatment of endometriosis: The estrogenthreshold hypothesis via openalex
- Immediate and delayed add‐back hormonal replacement therapy during ultra long GnRH agonist treatment of chronic cyclical pelvic pain via openalex
- Impact of GnRH agonist treatment on recurrence of ovarian endometriomas after conservative laparoscopic surgery via openalex
- One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double-blind trial via openalex
- The efficacy and tolerability of short-term low-dose estrogen-only add-back therapy during post-operative GnRH agonist treatment for endometriosis via openalex
- The role of add-back therapy in the United States. via openalex
- W4285719527 via openalex
- W201040832 via openalex
- W1969279914 via openalex
- W1995633792 via openalex
- W1998207473 via openalex
- W2037377025 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK